p53 supports healthy aging

p53 is a master regulator of cellular stress responses that is also implicated in the aging process. Its role in aging is often considered an example of antagonistic pleiotropy (AP), where it acts beneficially as a tumor suppressor early in life, but detrimentally in late life, for example by driving accumulation of stress-associated, pro-inflammatory senescent cells. However, the causal role of p53 in aging is not well-defined, and the AP model has not been definitively tested through loss- of-function studies. Here we show, contrary to the prediction of AP, that p53 promotes healthy aging in mouse liver by suppressing excessive inflammation and maintaining metabolic function. Multimodal RNA, protein, epigenetic and spatial profiling at the single-cell level in aged mouse liver confirmed age-dependent increase in p53 pathway activation. Hepatocyte-specific knockout of p53 in livers of aged mice, but not of young mice, increased inflammation and immune infiltration. Mechanistically, p53 suppressed DNA replication stress and DNA damage, known precursors to inflammatory signaling. In aged hepatocytes, p53 also directly targeted and maintained expression of metabolic genes, and knockout of p53 sensitized aged mice to metabolic stress-induced liver damage. Complementing these loss-of-function data, pharmacological activation of p53 with the small-molecule MDM2 inhibitor HDM201 in aged mice reversed age-associated suppression of metabolic genes, decreased age-associated inflammation and delayed onset of frailty. These results identify p53 activity in aged tissue as protective rather than degenerative. Importantly, this protective function is pharmacologically targetable, potentially for the benefit of healthy aging in humans.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-17
DOI
https://doi.org/10.64898/2026.11.16.766897
Primary Topic
Genetics, Aging, and Longevity in Model Organisms
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

p53 supports healthy aging

Peter D. Adams, Aaron P. Havas, Xue Lei, Armin Gandhi et al.
bioRxiv (Cold Spring Harbor Laboratory)
Genetics, Aging, and Longevity in Model Organisms
preprint

p53 supports healthy aging

Peter D. Adams, Aaron P. Havas, Xue Lei, Armin Gandhi, Nathan R. Zemke, Jessica M. Proulx, April E. Williams, K. Garrett Evensen, Alessandra Sacco, Marcos G. Teneche, Colin Kern, Allen Wang, Guillermina Garcia, Kevin M. Tharp, Quan Zhu, Tatiana M. Moreno, Christina Huan Shi, Yu Xin Wang, Andrea Rodríguez-Agustín, Sainath Mamde, Rebecca A. Porritt, Carolina Cano Macip, Bing Ren, Karl N. Miller, Caroline Kumsta, Laurence Haddadin, Hiroshi Tanaka, Cray Minor, Michael Alcaraz, Rouven Arnold, Adarsh Rajesh, Gabriele Guarnaccia, Erik Hultenius, Jacqueline Olness, Andrew Davis, Irene Huang, Kevin Y. Yip, Elizabeth W. Smoot, Monica Sevilla, Shreeya Patel, Kat Lande, Jake Castillo, Kelly Yichen Li
preprint en

Abstract

p53 is a master regulator of cellular stress responses that is also implicated in the aging process. Its role in aging is often considered an example of antagonistic pleiotropy (AP), where it acts beneficially as a tumor suppressor early in life, but detrimentally in late life, for example by driving accumulation of stress-associated, pro-inflammatory senescent cells. However, the causal role of p53 in aging is not well-defined, and the AP model has not been definitively tested through loss- of-function studies. Here we show, contrary to the prediction of AP, that p53 promotes healthy aging in mouse liver by suppressing excessive inflammation and maintaining metabolic function. Multimodal RNA, protein, epigenetic and spatial profiling at the single-cell level in aged mouse liver confirmed age-dependent increase in p53 pathway activation. Hepatocyte-specific knockout of p53 in livers of aged mice, but not of young mice, increased inflammation and immune infiltration. Mechanistically, p53 suppressed DNA replication stress and DNA damage, known precursors to inflammatory signaling. In aged hepatocytes, p53 also directly targeted and maintained expression of metabolic genes, and knockout of p53 sensitized aged mice to metabolic stress-induced liver damage. Complementing these loss-of-function data, pharmacological activation of p53 with the small-molecule MDM2 inhibitor HDM201 in aged mice reversed age-associated suppression of metabolic genes, decreased age-associated inflammation and delayed onset of frailty. These results identify p53 activity in aged tissue as protective rather than degenerative. Importantly, this protective function is pharmacologically targetable, potentially for the benefit of healthy aging in humans.

bioRxiv (Cold Spring Harbor Laboratory)
Salk Institute for Biological Studies (US), Sanford Burnham Prebys Medical Discovery Institute (US), Discovery Institute (US), University of California San Diego (US), New York Genome Center (US)
National Institute of Arthritis and Musculoskeletal and Skin Diseases, Common Fund
Good health and well-being
Genetics, Aging, and Longevity in Model Organisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon